© Brighton Collaboration 2023. All rights reserved.
Brighton Collaboration convenes experts around specific work areas to address the needs of the vaccine safety community. Brighton Collaboration sets up working groups to lead focused projects. View the working groups and projects below, and sort them by category.
(1 - 10 of 10)
On 8 and 9 November 2022, the Maternal Immunization Working Group (MIWG) held an in-person and online hybrid meeting. The objectives of the[...]
Rare adverse events following immunization (AEFIs) occurring in <1 per 10,000 vaccine recipients may not be detected in prelicensure clinical trials. The success[...]
In recognition of the increasing importance of viral vectors for the development of new vaccines and the need to understand their associated safety[...]
Background: In 2010, a safety signal was detected for narcolepsy following vaccination with Pandemrix, an AS03-adjuvanted monovalent pandemic H1N1 influenza (pH1N1) vaccine. To[...]
Immunization in pregnancy is a promising public health strategy to reduce illness and death among pregnant women and young infants. This is particularly[...]
The Brighton Collaboration (BC) Viral Vector Vaccines Safety Working Group (V3SWG) was renamed to Benefit-Risk Assessment of VAccines by TechnolOgy (BRAVATO) in July[...]